Cariprazine in the treatment of acute mania in bipolar disorder: a double-blind, placebo-controlled, phase III trial

被引:6
|
作者
Bose, A. [1 ]
Starace, A. [1 ]
Wang, Q. [1 ]
Diaz, E. [1 ]
Goodman, J. [1 ]
Ruth, A. [2 ]
Nemeth, G. [3 ]
Laszlovszky, I. [3 ]
机构
[1] Forest Res Inst, Jersey City, NJ USA
[2] Prescott Med Commun Grp, Chicago, IL USA
[3] Gedeon Richter Plc, Div Med, Budapest, Hungary
关键词
D O I
10.1016/S0924-977X(12)70432-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S285 / S285
页数:1
相关论文
共 50 条
  • [21] A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents
    Wagner, KD
    Kowatch, RA
    Emslie, GJ
    Findling, RL
    Wilens, TE
    McCague, K
    D'Souza, J
    Wamil, A
    Lehman, RB
    Berv, D
    Linden, D
    AMERICAN JOURNAL OF PSYCHIATRY, 2006, 163 (07): : 1179 - 1186
  • [22] Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: A multicenter, randomized, double-blind, placebo-controlled trial
    Weisler, RH
    Keck, PE
    Swann, AC
    Cutler, AJ
    Ketter, TA
    Kalali, AH
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (03) : 323 - 330
  • [23] Efficacy and Safety of Low- and High-Dose Cariprazine in Acute and Mixed Mania Associated With Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study
    Calabrese, Joseph R.
    Keck, Paul E., Jr.
    Starace, Anju
    Lu, Kaifeng
    Ruth, Adam
    Laszlovszky, Istvan
    Nemeth, Gyoergy
    Durgam, Suresh
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (03) : 284 - 292
  • [24] LECITHIN IN THE TREATMENT OF MANIA - DOUBLE-BLIND, PLACEBO-CONTROLLED TRIALS
    COHEN, BM
    LIPINSKI, JF
    ALTESMAN, RI
    AMERICAN JOURNAL OF PSYCHIATRY, 1982, 139 (09): : 1162 - 1164
  • [25] Efficacy and safety of palmitoylethanolamide as an adjunctive treatment for acute mania: A randomized, double-blind, placebo-controlled trial
    Abedini, Talieh
    Hosseyni, Reyhaneh
    Ghannadi, Farnaz
    Moghaddam, Hossein Sanjari
    Ardakani, Mohammad-Reza Khodaei
    Talaei, Ali
    Akhondzadeh, Shahin
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2022, 76 (10) : 505 - 511
  • [26] Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial
    Muller, Jacqueline E.
    Wentzel, Ignatius
    Koen, Liezl
    Niehaus, Dana J. H.
    Seedat, Soraya
    Stein, Dan J.
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2008, 23 (01) : 43 - 48
  • [27] Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial
    Akhondzadeh, S
    Erfani, S
    Mohammadi, MR
    Tehrani-Doost, M
    Amini, H
    Gudarzi, SS
    Yasamy, MT
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (02) : 145 - 150
  • [28] A double-blind, randomized, placebo-controlled study of allopurinol as adjunctive treatment for acute mania in hospitalized bipolar patients
    Akhondzadeh, S
    Milajerdi, MR
    Amini, H
    Moinalghorabaei, M
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (05) : 634 - 634
  • [29] Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study
    Earley, Willie R.
    Burgess, Maria V.
    Khan, Barbara
    Rekeda, Ludmyla
    Suppes, Trisha
    Tohen, Mauricio
    Calabrese, Joseph R.
    BIPOLAR DISORDERS, 2020, 22 (04) : 372 - 384
  • [30] A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania
    Keck, PE
    Marcus, R
    Tourkodimitris, S
    Ali, M
    Liebeskind, A
    Saha, A
    Ingenito, G
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (09): : 1651 - 1658